IL115885A0 - Pharmaceutical compositions comprising carbazoles and cyclodextrins - Google Patents
Pharmaceutical compositions comprising carbazoles and cyclodextrinsInfo
- Publication number
- IL115885A0 IL115885A0 IL11588595A IL11588595A IL115885A0 IL 115885 A0 IL115885 A0 IL 115885A0 IL 11588595 A IL11588595 A IL 11588595A IL 11588595 A IL11588595 A IL 11588595A IL 115885 A0 IL115885 A0 IL 115885A0
- Authority
- IL
- Israel
- Prior art keywords
- carbazoles
- cyclodextrins
- pharmaceutical compositions
- pharmaceutical
- compositions
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nanotechnology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP94203242 | 1994-11-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
IL115885A0 true IL115885A0 (en) | 1996-01-31 |
Family
ID=8217355
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL11588595A IL115885A0 (en) | 1994-11-07 | 1995-11-06 | Pharmaceutical compositions comprising carbazoles and cyclodextrins |
Country Status (5)
Country | Link |
---|---|
AU (1) | AU3846395A (xx) |
IL (1) | IL115885A0 (xx) |
TR (1) | TR199501376A2 (xx) |
WO (1) | WO1996014090A1 (xx) |
ZA (1) | ZA959388B (xx) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ330596A (en) | 1998-06-05 | 2001-02-23 | Dec Res | Intravaginal devices allowing for increased uptake of active ingredients |
US6683100B2 (en) | 1999-01-19 | 2004-01-27 | Novartis Ag | Organic compounds |
US6194181B1 (en) | 1998-02-19 | 2001-02-27 | Novartis Ag | Fermentative preparation process for and crystal forms of cytostatics |
CN1900079A (zh) | 2000-11-17 | 2007-01-24 | 武田药品工业株式会社 | 新咪唑衍生物、其制备方法及其用途 |
CA2429437A1 (en) | 2000-11-20 | 2002-05-23 | Takeda Chemical Industries, Ltd. | Imidazole derivatives, process for their preparation and their use |
WO2002046186A1 (fr) | 2000-12-08 | 2002-06-13 | Takeda Chemical Industries, Ltd. | Dérivés thiazole substitués porteurs de groupes 3-pyridyl, procédé d'élaboration et leur utilisation |
PL2445903T3 (pl) | 2009-06-26 | 2014-08-29 | Novartis Ag | 1,3-Di-podstawione pochodne imidazolidyn-2-onu jako inhibitory CYP 17 |
CA2779309A1 (en) * | 2009-10-23 | 2011-04-28 | Health Research, Inc. | Method for treating androgen receptor positive cancers |
EP2600855A2 (en) | 2010-08-04 | 2013-06-12 | Pellficure Pharmaceuticals, Inc. | Combination therapy for the treatment of prostate carcinoma |
CN103108871B (zh) | 2010-09-16 | 2014-09-10 | 诺华股份有限公司 | 17α-羟化酶/C17,20-裂合酶抑制剂 |
MX359399B (es) | 2011-04-28 | 2018-09-27 | Novartis Ag | Inhibidores de 17alfa-hidroxilasa/c17-20-liasa. |
US20160022606A1 (en) | 2013-03-14 | 2016-01-28 | Pellficure Pharmaceuticals Inc. | Novel therapy for prostate carcinoma |
US10093620B2 (en) | 2014-09-12 | 2018-10-09 | Pellficure Pharmaceuticals, Inc. | Compositions and methods for treatment of prostate carcinoma |
EP3528799A1 (en) | 2016-10-24 | 2019-08-28 | Pellficure Pharmaceuticals, Inc. | Pharmaceutical compositions of 5-hydroxy-2-methylnaphthalene-1, 4-dione |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9310635D0 (en) * | 1993-05-21 | 1993-07-07 | Glaxo Group Ltd | Chemical compounds |
-
1995
- 1995-10-31 AU AU38463/95A patent/AU3846395A/en not_active Abandoned
- 1995-10-31 WO PCT/EP1995/004295 patent/WO1996014090A1/en active Application Filing
- 1995-11-06 IL IL11588595A patent/IL115885A0/xx unknown
- 1995-11-06 ZA ZA959388A patent/ZA959388B/xx unknown
- 1995-11-07 TR TR95/01376A patent/TR199501376A2/xx unknown
Also Published As
Publication number | Publication date |
---|---|
ZA959388B (en) | 1997-05-06 |
TR199501376A2 (tr) | 1996-06-21 |
WO1996014090A1 (en) | 1996-05-17 |
AU3846395A (en) | 1996-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL114622A0 (en) | Heteroaryl-oxazolidinones and pharmaceutical compositions containing them | |
IL119078A (en) | Substituted benzylaminopiperidine compounds and pharmaceutical compositions comprising them | |
IL122485A0 (en) | Arylsulfonylaminobenzene derivatives and pharmaceutical compositions containg the same | |
IL116851A (en) | 3-arylidene-2-oxindole derivatives and pharmaceutical compositions containing them | |
HUP9900424A2 (hu) | Tiazolil-benzfurán-származékok és a vegyületeket tartalmazó gyógyászati készítmények | |
IL135990A0 (en) | Pharmaceutical compositions containing cyclodextrins and taxoids | |
AU5856898A (en) | Heteroarylsulfonamide derivatives and pharmaceutical compositions containing them | |
IL115885A0 (en) | Pharmaceutical compositions comprising carbazoles and cyclodextrins | |
ZA967800B (en) | Heteroaryllsubstituted acryloylguanidine derivatives and pharmaceutical compositions comprising them | |
EP0755250A4 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING BENZAMIDE | |
HUP9602196A2 (en) | Sulfonyl- and sulfinyl-benzoyl-guanidine derivatives and pharmaceutical compositions thereof | |
HUP0000460A3 (en) | Imidazopyridazines and pharmaceutical compositions thereof | |
IL120722A0 (en) | Carbohydrate derivatives and pharmaceutical compositions containing them | |
GB9501286D0 (en) | Pharmaceutical compositions and preparations thereof | |
IL115982A (en) | Cyclolignan derivatives and pharmaceutical compositions containing them | |
ZA982457B (en) | Pharmaceutical compositions containing propanaminde derivatives and cyclodextrin | |
HUP9802291A3 (en) | Penicillaminamide derivatives and pharmaceutical compositions containing them | |
HUP0000275A3 (en) | Phenanethridinium derivatives and pharmaceutical compositions containing them | |
IL117618A0 (en) | Diphenylmethyl-azetidinone derivatives and pharmaceutical compositions containing the same | |
GB2295825B (en) | Pharmaceutical compositions | |
IL115882A0 (en) | Oxazolyl-and thiazolylimidazo-benzo-and thienodiazepines their manufacture and pharmaceutical compositions containing them | |
HUP9901968A3 (en) | 2-thioxotetrahydropyrimidin-4-one derivatives and pharmaceutical compositions containing them | |
GB9400047D0 (en) | Pharmaceutical compositions | |
IL117155A0 (en) | Quinolizinone derivatives and pharmaceutical compositions containing the same | |
ZA974422B (en) | Substituted-amidinobenzene derivative and pharmaceutical compositions thereof. |